India Veterinary Medicine Market Size & Outlook, 2026-2033
The veterinary medicine market in India is expected to reach a projected revenue of US$ 4,239.4 million by 2033. A compound annual growth rate of 12.4% is expected of India veterinary medicine market from 2026 to 2033.
Zoetis Inc Class A, Boehringer Ingelheim, Merck & Co Inc, Elanco Animal Health Inc, Dechra Pharmaceuticals, Ceva Santé Animale, Phibro Animal Health Corp Class A, Virbac SA, Bimeda Ireland, Biogenesis Bago
Other key industry trends
In terms of revenue, India accounted for 3.3% of the global veterinary medicine market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, China veterinary medicine market is projected to lead the regional market in terms of revenue in 2033.
India is the fastest growing regional market in Asia Pacific and is projected to reach USD 4,239.4 million by 2033.
The veterinary medicine market is expected to grow at a CAGR of 10.3% over the forecast period owing to rising government efforts to boost veterinary healthcare facilities and various funding schemes delivered by the state as well as the national government.
The states of Rajasthan, Uttar Pradesh, and Punjab collectively accounted for over 50% of the veterinary hospitals/polyclinics. The government is providing funding for establishing and strengthening existing veterinary hospitals & dispensaries, thereby increasing growth opportunities in India.
One of the main providers of pet insurance, which can pay for procedures and hospitalization, is Bajaj Allianz. Other prominent providers are New India Assurance, Vetina Paw tect, and Oriental Insurance. There are also livestock insurance schemes in India, due to the large population of production animals in the country.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Veterinary Medicine Market Outlook will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 62.84% in 2025.
Horizon Databook has segmented the India veterinary medicine market based on biologics, pharmaceuticals, medicated feed additives covering the revenue growth of each sub-segment from 2021 to 2033.
The veterinary medicine market is expected to grow at a CAGR of 10.3% over the forecast period owing to rising government efforts to boost veterinary healthcare facilities and various funding schemes delivered by the state as well as the national government.
The states of Rajasthan, Uttar Pradesh, and Punjab collectively accounted for over 50% of the veterinary hospitals/polyclinics. The government is providing funding for establishing and strengthening existing veterinary hospitals & dispensaries, thereby increasing growth opportunities in India.
One of the main providers of pet insurance, which can pay for procedures and hospitalization, is Bajaj Allianz. Other prominent providers are New India Assurance, Vetina Paw tect, and Oriental Insurance. There are also livestock insurance schemes in India, due to the large population of production animals in the country.
India Veterinary Medicine Market Product Outlook (Revenue, USD Million , 2021-2033)
Biologics
Pharmaceuticals
Medicated Feed Additives
India Veterinary Medicine Market Animal Type Outlook (Revenue, USD Million , 2021-2033)
Companion Animals
Production Animals
India Veterinary Medicine Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
Oral
Other Routes
Injectable
Topical
India Veterinary Medicine Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
E-commerce
Offline Retail Stores
Others
Veterinary Hospitals & Clinics
Reasons to subscribe to Veterinary Medicine Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Veterinary Medicine Market Outlook databook
Our clientele includes a mix of Veterinary Medicine Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India Veterinary Medicine Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into India Veterinary Medicine Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
India Veterinary Medicine Market, 2021-2033 (US$M)